Lv5
1020 积分 2025-11-11 加入
Neoadjuvant Chemoimmunotherapy for NSCLC
1个月前
已完结
A guide to understanding tumour evolution through the lens of population genetics
1个月前
已完结
Multidisciplinary assessment of patients with extensive stage small cell lung cancer: A geriatric tumor board
1个月前
已完结
Metastasis‐directed radiation therapy may improve progression‐free survival in patients with oligometastatic solid tumors
1个月前
已完结
Early stage nonsmall cell lung cancer: Toward a risk‐adaptive paradigm in the era of biologic precision
1个月前
已完结
Redefining early stage nonsmall cell lung cancer: The dawn of the risk‐adaptive and biologically precise era
1个月前
已关闭
Lung Transplant for Refractory Lung-Limited Stage IV Non–Small Cell Lung Cancer
1个月前
已完结
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
SHR-A2102, a nectin-4 directed antibody–drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial
1个月前
已完结
Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers
1个月前
已完结
皖公网安备34019202002308
